Titre : Vietnam

Vietnam : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pigmentation Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vietnam : Questions médicales les plus fréquentes", "headline": "Vietnam : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vietnam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vietnam" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asie du Sud-Est", "url": "https://questionsmedicales.fr/mesh/D001210", "about": { "@type": "MedicalCondition", "name": "Asie du Sud-Est", "code": { "@type": "MedicalCode", "code": "D001210", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.145" } } }, "about": { "@type": "MedicalCondition", "name": "Vietnam", "alternateName": "Vietnam", "code": { "@type": "MedicalCode", "code": "D014744", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Pham Quang Thai", "url": "https://questionsmedicales.fr/author/Pham%20Quang%20Thai", "affiliation": { "@type": "Organization", "name": "National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam." } }, { "@type": "Person", "name": "Le Van Tan", "url": "https://questionsmedicales.fr/author/Le%20Van%20Tan", "affiliation": { "@type": "Organization", "name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam." } }, { "@type": "Person", "name": "Marc Choisy", "url": "https://questionsmedicales.fr/author/Marc%20Choisy", "affiliation": { "@type": "Organization", "name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK." } }, { "@type": "Person", "name": "H Rogier van Doorn", "url": "https://questionsmedicales.fr/author/H%20Rogier%20van%20Doorn", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "H T Nguyen", "url": "https://questionsmedicales.fr/author/H%20T%20Nguyen", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Recent Advances in the Therapeutic Potential of Carotenoids in Preventing and Managing Metabolic Disorders.", "datePublished": "2024-06-07", "url": "https://questionsmedicales.fr/article/38931016", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/plants13121584" } }, { "@type": "ScholarlyArticle", "name": "Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders.", "datePublished": "2024-06-06", "url": "https://questionsmedicales.fr/article/38931409", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ph17060741" } }, { "@type": "ScholarlyArticle", "name": "Impact of Disease-modifying Therapies on Respiratory Function in People with Neuromuscular Disorders.", "datePublished": "2024-06-04", "url": "https://questionsmedicales.fr/article/39095144", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jsmc.2024.04.004" } }, { "@type": "ScholarlyArticle", "name": "Multidisciplinary Care for Moebius Syndrome and Related Disorders: Building a Management Protocol.", "datePublished": "2024-06-04", "url": "https://questionsmedicales.fr/article/38893020", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/jcm13113309" } }, { "@type": "ScholarlyArticle", "name": "International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders: A Consensus Statement.", "datePublished": "2024-06-03", "url": "https://questionsmedicales.fr/article/38869906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.16760" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Asie", "item": "https://questionsmedicales.fr/mesh/D001208" }, { "@type": "ListItem", "position": 4, "name": "Asie du Sud-Est", "item": "https://questionsmedicales.fr/mesh/D001210" }, { "@type": "ListItem", "position": 5, "name": "Vietnam", "item": "https://questionsmedicales.fr/mesh/D014744" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vietnam - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vietnam", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vietnam", "description": "Comment diagnostiquer la dengue au Vietnam ?\nQuels tests pour le paludisme au Vietnam ?\nComment identifier la tuberculose ?\nQuels signes pour le choléra ?\nComment détecter une infection à VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Pigmentation+Disorders&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vietnam", "description": "Quels symptômes de la dengue ?\nQuels signes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du choléra ?\nQuels symptômes d'une infection à VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Pigmentation+Disorders&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vietnam", "description": "Comment prévenir la dengue ?\nQuelles mesures pour prévenir le paludisme ?\nComment prévenir la tuberculose ?\nQuelles précautions contre le choléra ?\nComment prévenir le VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Pigmentation+Disorders&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vietnam", "description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la tuberculose ?\nComment traiter le choléra ?\nQuel traitement pour le VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Pigmentation+Disorders&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vietnam", "description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du choléra ?\nQuelles complications du VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Pigmentation+Disorders&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vietnam", "description": "Quels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le choléra ?\nQuels facteurs de risque pour le VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Pigmentation+Disorders&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la dengue au Vietnam ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral." } }, { "@type": "Question", "name": "Quels tests pour le paludisme au Vietnam ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme." } }, { "@type": "Question", "name": "Comment identifier la tuberculose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures." } }, { "@type": "Question", "name": "Quels signes pour le choléra ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra se diagnostique par des selles liquides et des tests de laboratoire." } }, { "@type": "Question", "name": "Comment détecter une infection à VIH ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents." } }, { "@type": "Question", "name": "Quels signes du paludisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques." } }, { "@type": "Question", "name": "Quels symptômes de la tuberculose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants." } }, { "@type": "Question", "name": "Quels signes du choléra ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques." } }, { "@type": "Question", "name": "Quels symptômes d'une infection à VIH ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés." } }, { "@type": "Question", "name": "Comment prévenir la dengue ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques." } }, { "@type": "Question", "name": "Quelles mesures pour prévenir le paludisme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Quelles précautions contre le choléra ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Boire de l'eau potable, se laver les mains et consommer des aliments cuits." } }, { "@type": "Question", "name": "Comment prévenir le VIH ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH." } }, { "@type": "Question", "name": "Quel traitement pour la dengue ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois." } }, { "@type": "Question", "name": "Comment traiter le choléra ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Quel traitement pour le VIH ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH est traité par des antirétroviraux pour contrôler la charge virale." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dengue sévère, le choc et des hémorragies." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère peut entraîner un choc hypovolémique et la mort." } }, { "@type": "Question", "name": "Quelles complications du VIH ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH peut mener à des infections opportunistes et à des cancers associés." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones endémiques, absence de protection contre les moustiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Conditions de vie précaires, immunodépression et contact avec des malades." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le choléra ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le VIH ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Relations sexuelles non protégées, partage de seringues et absence de dépistage." } } ] } ] }

Sources (10000 au total)

International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders: A Consensus Statement.

The use of evidence-based standardized outcome measures is increasingly recognized as key to guiding clinical decision-making in mental health. Implementation of these measures into clinical practice ... To develop a core set of outcome measures for specific neurodevelopmental disorders (NDDs), such as attention-deficit/hyperactivity disorder (ADHD), communication disorders, specific learning disorder... An international working group composed of clinical and research experts and service users (n = 27) was convened to develop a standard core set of accessible, valid, and reliable outcome measures for ... The final set recommends measuring 12 outcomes across 3 key domains: (1) core symptoms related to the diagnosis; (2) impact, functioning, and quality of life; and (3) common coexisting problems. The f... The NDD set covers outcomes of most concern to patients and caregivers. Use of the NDD set has the potential to improve clinical practice and research....

Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities.

Medications for opioid use disorder (MOUD) are an effective but underutilized treatment. Opioid use disorder prevalence is high among people receiving treatment in community outpatient mental health t... To quantify availability of MOUD at community outpatient MHTFs in high-burden states as well as characteristics associated with offering MOUD.... This cross-sectional study performed a phone survey between April and July 2023 among a representative sample of community outpatient MHTFs within 20 states most affected by the opioid crisis, includi... MOUD availability. A multivariable logistic regression was fit to assess associations of facility, county, and state-level characteristics with offering MOUD.... Surveys with staff from 450 community outpatient MHTFs (152 CCBHCs and 298 non-CCBHCs) in 20 states were analyzed. Weighted estimates found that 34% (95% CI, 29%-39%) of MHTFs offered MOUD in these st... In this study of 450 community outpatient MHTFs in 20 high-burden states, approximately one-third offered MOUD. These results suggest that further study is needed to report MOUD uptake, either through...